Cipla net up 47% to Rs 180 crore

BS 200 SCORECARD

The country's second largest pharmaceutical company, Cipla, posted a 47.04 per cent growth in net profit at Rs 180.28 crore for the quarter ended September 30 as compared with Rs 122.60 crore for the same period last year.

The company's total income increased to Rs 915.10 crore from Rs 673.23 crore, up by 35.92 per cent, during the period under review.

The company sources said the growth in domestic sales and the increased revenue from global supply alliances have resulted in the substantial jump in the income and the profits.

Cipla is currently on a major capacity expansion drive. The company is planning to acquire 80 acre for setting up the largest pharmaceutical formulation plant in the country.

The plant, with an investment of about Rs 650 crore, is coming up in the Bhootkhamb SEZ near Keri in Goa.